收费全文 | 187581篇 |
免费 | 15208篇 |
国内免费 | 4833篇 |
耳鼻咽喉 | 1968篇 |
儿科学 | 9274篇 |
妇产科学 | 4222篇 |
基础医学 | 18963篇 |
口腔科学 | 2061篇 |
临床医学 | 20971篇 |
内科学 | 29108篇 |
皮肤病学 | 2943篇 |
神经病学 | 12756篇 |
特种医学 | 4396篇 |
外国民族医学 | 14篇 |
外科学 | 23272篇 |
综合类 | 28342篇 |
现状与发展 | 23篇 |
一般理论 | 2篇 |
预防医学 | 12739篇 |
眼科学 | 2693篇 |
药学 | 12285篇 |
121篇 | |
中国医学 | 17015篇 |
肿瘤学 | 4454篇 |
2024年 | 2039篇 |
2023年 | 3555篇 |
2022年 | 6529篇 |
2021年 | 8763篇 |
2020年 | 8283篇 |
2019年 | 6708篇 |
2018年 | 6705篇 |
2017年 | 6736篇 |
2016年 | 7137篇 |
2015年 | 6853篇 |
2014年 | 12832篇 |
2013年 | 13788篇 |
2012年 | 10624篇 |
2011年 | 11845篇 |
2010年 | 9279篇 |
2009年 | 8862篇 |
2008年 | 8647篇 |
2007年 | 8803篇 |
2006年 | 7925篇 |
2005年 | 6752篇 |
2004年 | 5830篇 |
2003年 | 5129篇 |
2002年 | 3674篇 |
2001年 | 3333篇 |
2000年 | 2806篇 |
1999年 | 2520篇 |
1998年 | 2102篇 |
1997年 | 2000篇 |
1996年 | 1901篇 |
1995年 | 1838篇 |
1994年 | 1635篇 |
1993年 | 1429篇 |
1992年 | 1282篇 |
1991年 | 1056篇 |
1990年 | 991篇 |
1989年 | 849篇 |
1988年 | 777篇 |
1987年 | 714篇 |
1986年 | 581篇 |
1985年 | 810篇 |
1984年 | 658篇 |
1983年 | 432篇 |
1982年 | 512篇 |
1981年 | 451篇 |
1980年 | 388篇 |
1979年 | 298篇 |
1978年 | 248篇 |
1977年 | 170篇 |
1976年 | 168篇 |
1975年 | 91篇 |
Background
There are conflicting data regarding the relative effectiveness of renal sympathetic denervation (RSD) in patients with hypertension.Objectives
The purpose of this study was to evaluate the blood pressure (BP) response after RSD in sham-controlled randomized trials.Methods
Databases were searched through June 30, 2018. Randomized trials (RCTs) with ≥50 patients comparing catheter-based RSD with a sham control were included. The authors calculated summary treatment estimates as weighted mean differences (WMD) with 95% confidence intervals (CIs) using random-effects meta-analysis.Results
The analysis included 977 patients from 6 trials. The reduction in 24-h ambulatory systolic blood pressure (ASBP) was significantly greater for patients treated with RSD than sham procedure (WMD ?3.65 mm Hg, 95% CI: ?5.33 to ?1.98; p < 0.001). Compared with sham, RSD was also associated with a significant decrease in daytime ASBP (WMD ?4.07 mm Hg, 95% CI: ?6.46 to ?1.68; p < 0.001), office systolic BP (WMD ?5.53 mm Hg, 95% CI: ?8.18 to ?2.87; p < 0.001), 24-h ambulatory diastolic BP (WMD ?1.71 mm Hg, 95% CI: ?3.06 to ?0.35; p = 0.01), daytime ambulatory diastolic BP (WMD ?1.57 mm Hg, 95% CI: ?2.73 to ?0.42; p = 0.008), and office diastolic BP (WMD ?3.37 mm Hg, 95% CI: ?4.86 to ?1.88; p < 0.001). Compared with first-generation trials, a significantly greater reduction in daytime ASBP was observed with RSD in second-generation trials (6.12 mm Hg vs. 2.14 mm Hg; p interaction = 0.04); however, this interaction was not significant for 24-h ASBP (4.85 mm Hg vs. 2.23 mm Hg; p interaction = 0.13).Conclusions
RSD significantly reduced blood pressure compared with sham control. Results of this meta-analysis should inform the design of larger, pivotal trials to evaluate the long-term efficacy and safety of RSD in patients with hypertension. 相似文献Areas covered: Herein, the authors review genetic, demographic, socioeconomic, nutritional and lifestyle risks associated with schizophrenia in pregnancy. They also cover specific risks associated with typical antipsychotic medications, specific risks associated with atypical antipsychotic medications, risks associated with polypharmacy and risks of developmental delay in children exposed to antipsychotic medications in utero.
Expert opinion: Our understanding of the risks that women with schizophrenia face in pregnancy from their illness and from the treatment they receive continues to evolve. As our ability to analyze data progresses, the risks conferred by antipsychotic medication treatment appear to lessen in clinical and statistical significance, whilst the true risks to these women and their babies from their experience of disadvantage continue to set them aside from the general population. Reducing polypharmacy and providing comprehensive and supportive care can minimize harm to women with schizophrenia and their babies. 相似文献